RAN-CITALO DIN 02285630
Status: Cancelled Post Market
Holder: RANBAXY PHARMACEUTICALS CANADA INC.
Molecule: CITALOPRAM (CITALOPRAM HYDROBROMIDE)
Health Canada record
| Active ingredient(s) | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 40 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N06AB04 CITALOPRAM |
| Original market date | 07-Dec-2006 |
| Current status date | 30-Sep-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
Ranbaxy Pharmaceuticals Canada Inc. (a SUN PHARMA Company) — licence 101281, not currently licensed, last inspection rating C (2022-02-01).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CITALOPRAM (CITALOPRAM HYDROBROMIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02295431 | ACT CITALOPRAM | KNIGHT THERAPEUTICS INC. | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 30 MG | Approved |
| 02246057 | APO-CITALOPRAM | APOTEX INC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 40 MG | Marketed |
| 02246056 | APO-CITALOPRAM | APOTEX INC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 20 MG | Marketed |
| 02275570 | AURO-CITALOPRAM | AURO PHARMA INC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 40 MG | Marketed |
| 02275562 | AURO-CITALOPRAM | AURO PHARMA INC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 20 MG | Marketed |
| 02239606 | CELEXA 10 MG | LUNDBECK CANADA INC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 10 MG | Approved |
| 02239607 | CELEXA 20 MG | LUNDBECK CANADA INC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 20 MG | Marketed |
| 02239608 | CELEXA 40 MG | LUNDBECK CANADA INC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 40 MG | Marketed |
| 02296152 | CTP 30 | KNIGHT THERAPEUTICS INC. | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 30 MG | Marketed |
| 02302535 | IPG-CITALOPRAM | MARCAN PHARMACEUTICALS INC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 20 MG | Approved |
| 02302543 | IPG-CITALOPRAM | MARCAN PHARMACEUTICALS INC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 40 MG | Approved |
| 02313413 | JAMP-CITALOPRAM | JAMP PHARMA CORPORATION | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 40 MG | Marketed |
| 02313405 | JAMP-CITALOPRAM | JAMP PHARMA CORPORATION | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 20 MG | Marketed |
| 02248010 | PMS-CITALOPRAM | PHARMASCIENCE INC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 20 MG | Marketed |
| 02248011 | PMS-CITALOPRAM | PHARMASCIENCE INC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 40 MG | Marketed |
| 02270609 | PMS-CITALOPRAM | PHARMASCIENCE INC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 10 MG | Marketed |
| 02257513 | PRO-CITALOPRAM | PRO DOC LIMITEE | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 20 MG | Marketed |
| 02257521 | PRO-CITALOPRAM | PRO DOC LIMITEE | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 40 MG | Marketed |
| 02303264 | RIVA-CITALOPRAM | LABORATOIRE RIVA INC. | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 20 MG | Marketed |
| 02303272 | RIVA-CITALOPRAM | LABORATOIRE RIVA INC. | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 40 MG | Marketed |
| 02303256 | RIVA-CITALOPRAM | LABORATOIRE RIVA INC. | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 10 MG | Marketed |
| 02293218 | TEVA-CITALOPRAM | TEVA CANADA LIMITED | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 20 MG | Marketed |
| 02293226 | TEVA-CITALOPRAM | TEVA CANADA LIMITED | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 40 MG | Marketed |
| 02312336 | TEVA-CITALOPRAM | TEVA CANADA LIMITED | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 10 MG | Marketed |
| 02248050 | ACT CITALOPRAM | SUNOVION PHARMACEUTICALS CANADA INC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 20 MG | Cancelled Post Market |
| 02248051 | ACT CITALOPRAM | SUNOVION PHARMACEUTICALS CANADA INC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 40 MG | Cancelled Post Market |
| 02284847 | CITALOPRAM | MYLAN PHARMACEUTICALS ULC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 20 MG | Cancelled Post Market |
| 02301849 | CITALOPRAM | MELIAPHARM INC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 40 MG | Cancelled Post Market |
| 02301830 | CITALOPRAM | MELIAPHARM INC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 20 MG | Cancelled Post Market |
| 02301822 | CITALOPRAM | MELIAPHARM INC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 10 MG | Cancelled Post Market |
| 02284855 | CITALOPRAM | MYLAN PHARMACEUTICALS ULC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 40 MG | Cancelled Post Market |
| 02306239 | CITALOPRAM-ODAN | ODAN LABORATORIESLTD | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 20 MG | Cancelled Post Market |
| 02306247 | CITALOPRAM-ODAN | ODAN LABORATORIESLTD | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 40 MG | Cancelled Post Market |
| 02273055 | DOM-CITALOPRAM | DOMINION PHARMACAL | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 10 MG | Cancelled Post Market |
| 02248943 | DOM-CITALOPRAM | DOMINION PHARMACAL | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 40 MG | Cancelled Post Market |
| 02248942 | DOM-CITALOPRAM | DOMINION PHARMACAL | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 20 MG | Cancelled Post Market |
| 02304694 | MINT-CITALOPRAM | MINT PHARMACEUTICALS INC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 40 MG | Cancelled Post Market |
| 02304686 | MINT-CITALOPRAM | MINT PHARMACEUTICALS INC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 20 MG | Cancelled Post Market |
| 02246594 | MYLAN-CITALOPRAM | MYLAN PHARMACEUTICALS ULC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 20 MG | Cancelled Post Market |
| 02246593 | MYLAN-CITALOPRAM | MYLAN PHARMACEUTICALS ULC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 10 MG | Cancelled Pre Market |
| 02246595 | MYLAN-CITALOPRAM | MYLAN PHARMACEUTICALS ULC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 40 MG | Cancelled Post Market |
| 02322803 | NG CITALOPRAM | NEXT GENERATION PHARMA INC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 40 MG | Cancelled Post Market |
| 02322781 | NG CITALOPRAM | NEXT GENERATION PHARMA INC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 20 MG | Cancelled Post Market |
| 02251558 | NOVO-CITALOPRAM | NOVOPHARM LIMITED | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 20 MG | Cancelled Post Market |
| 02251566 | NOVO-CITALOPRAM | NOVOPHARM LIMITED | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 40 MG | Cancelled Post Market |
| 02248996 | NU-CITALOPRAM | NU-PHARM INC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 20 MG | Cancelled (Unreturned Annual) |
| 02248997 | NU-CITALOPRAM | NU-PHARM INC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 40 MG | Cancelled (Unreturned Annual) |
| 02273543 | PHL-CITALOPRAM | PHARMEL INC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 10 MG | Cancelled Post Market |
| 02248945 | PHL-CITALOPRAM | PHARMEL INC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 40 MG | Cancelled Post Market |
| 02248944 | PHL-CITALOPRAM | PHARMEL INC | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 20 MG | Cancelled Post Market |
| 02285622 | RAN-CITALO | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 20 MG | Cancelled Post Market |
| 02268019 | RAN-CITALOPRAM | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 40 MG | Cancelled Post Market |
| 02268000 | RAN-CITALOPRAM | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 20 MG | Cancelled Post Market |
| 02252112 | RATIO-CITALOPRAM | TEVA CANADA LIMITED | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 20 MG | Cancelled Post Market |
| 02252120 | RATIO-CITALOPRAM | TEVA CANADA LIMITED | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 40 MG | Cancelled Post Market |
| 02249278 | RIVA-CITALOPRAM | LABORATOIRE RIVA INC. | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 20 MG | Cancelled Post Market |
| 02249286 | RIVA-CITALOPRAM | LABORATOIRE RIVA INC. | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 40 MG | Cancelled Post Market |
| 02249251 | RIVA-CITALOPRAM | LABORATOIRE RIVA INC. | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 10 MG | Cancelled Pre Market |
| 02248171 | SANDOZ CITALOPRAM | SANDOZ CANADA INCORPORATED | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 40 MG | Cancelled Post Market |
| 02248170 | SANDOZ CITALOPRAM | SANDOZ CANADA INCORPORATED | Tablet | CITALOPRAM (CITALOPRAM HYDROBROMIDE) 20 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 15618 | 2014-05-22 | Abbreviated New Drug Submission (ANDS) | LICENSING AGREEMENT BETWEEN TWO COMPANIES |
| 8437 | 2006-12-01 | Supplement to an Abbreviated New Drug Submission (SANDS) | PRODUCT NAME CHANGE |
| 8278 | 2006-09-22 | Abbreviated New Drug Submission (ANDS) |